Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

What's the Difference? Sepracor's Xopenex Hit Hard by Coverage Cut

Jul 01 2007

• By Michael McCaughan

Related Content

Lexapro: The First Victim of Part D?

Dec 01 2005

An Eye for an Eye: Lucentis and the New Pharmaceutical Value System

Jun 01 2007

Formulary 101: The Medicare Program Hosts A Cash Course In Therapeutic Alternatives

Jan 01 2006

NitroMed's BiDil Pricing: Test for a Whole Class of New Companies

Oct 01 2005

Insomnia: Pharma Wakes Up to the Next Huge CNS Market

Feb 01 2006

Living in a Bipolar World: Implications of the EPO Safety Debate (Part 1)

Jul 01 2007

Sepracor: Why Won't Companies Buy Low-Risk Research?

Apr 01 1997

Related Companies

Sumitomo Pharma Co., Ltd.

Forest Laboratories, Inc.

NitroMed, Inc.

Amgen, Inc.

GSK plc

Schering-Plough

Abbott

AstraZeneca PLC

Additional Topics

Reimbursement Government Payers

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window